Little House Capital LLC lifted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 47.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,492 shares of the company's stock after acquiring an additional 5,656 shares during the quarter. Little House Capital LLC's holdings in Procter & Gamble were worth $2,981,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in PG. Vanguard Group Inc. raised its holdings in Procter & Gamble by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 229,794,073 shares of the company's stock worth $38,524,976,000 after purchasing an additional 1,592,061 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Procter & Gamble by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 56,472,195 shares of the company's stock worth $9,457,000,000 after acquiring an additional 1,267,419 shares in the last quarter. Norges Bank purchased a new stake in Procter & Gamble during the fourth quarter valued at approximately $5,244,463,000. Northern Trust Corp boosted its stake in Procter & Gamble by 10.1% in the fourth quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock valued at $4,928,107,000 after acquiring an additional 2,703,757 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in Procter & Gamble by 6.4% in the fourth quarter. Franklin Resources Inc. now owns 20,197,996 shares of the company's stock worth $3,386,194,000 after purchasing an additional 1,209,275 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on the company. Redburn Atlantic lowered Procter & Gamble from a "buy" rating to a "neutral" rating and set a $161.00 price objective for the company. in a report on Thursday, May 1st. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a research report on Thursday, March 27th. Morgan Stanley set a $180.00 target price on shares of Procter & Gamble and gave the stock an "overweight" rating in a research report on Friday, April 25th. Citigroup decreased their price target on shares of Procter & Gamble from $200.00 to $181.00 and set a "buy" rating for the company in a report on Friday, April 25th. Finally, Evercore ISI reissued an "outperform" rating and set a $190.00 price objective (up from $170.00) on shares of Procter & Gamble in a report on Tuesday, June 3rd. Eight equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $178.45.
View Our Latest Stock Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other news, CEO Jennifer L. Davis sold 1,000 shares of the stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the transaction, the chief executive officer now owns 51,965 shares in the company, valued at $8,386,111.70. This trade represents a 1.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the business's stock in a transaction on Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the sale, the insider now directly owns 25,182 shares of the company's stock, valued at approximately $3,995,627.94. The trade was a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by company insiders.
Procter & Gamble Trading Up 0.9%
Procter & Gamble stock opened at $160.00 on Friday. The firm has a market cap of $375.11 billion, a PE ratio of 25.40, a P/E/G ratio of 4.71 and a beta of 0.43. Procter & Gamble Company has a 12 month low of $156.58 and a 12 month high of $180.43. The stock's 50 day simple moving average is $162.44 and its two-hundred day simple moving average is $165.62. The company has a current ratio of 0.71, a quick ratio of 0.50 and a debt-to-equity ratio of 0.47.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. During the same period in the prior year, the firm posted $1.52 earnings per share. The firm's quarterly revenue was down 2.1% compared to the same quarter last year. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Monday, April 21st were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Monday, April 21st. This is a boost from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.64%. Procter & Gamble's dividend payout ratio (DPR) is 67.14%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report